Patent holdings for IPC class C07D 305/14

Total number of patents in this class: 306

10-year publication summary

14
17
16
12
16
8
8
13
13
4
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Indena S.p.A.
626
12
Nektar Therapeutics
438
7
Aventis Pharma S.A.
54
6
Fresenius Kabi Oncology Limited
66
6
Novomer, Inc.
212
6
Alethia Biotherapeutics Inc.
21
5
Shenyang Pharmaceutical University
108
5
Starpharma Pty Limited
69
5
The University of British Columbia
1495
5
Shanghai Parling Pharma-Tech. Co., Ltd.
5
5
6570763 Canada Inc.
4
4
Hanmi Pharm. Co., Ltd.
571
4
The Research Foundation for The State University of New York
1621
4
Shilpa Medicare Limited
110
4
Tapestry Pharmaceuticals, Inc.
26
4
AstraZeneca AB
2892
3
Life Technologies Corporation
3306
3
Dalian Institute of Chemical Physics, Chinese Academy of Sciences
671
3
Inner Mongolia Puyin Pharmaceutical Co., Ltd
10
3
Institute of Materia Medica, Chinese Academy of Medical Sciences
178
3
Other owners 209